000 01658 a2200481 4500
005 20250515221711.0
264 0 _c20110616
008 201106s 0 0 eng d
022 _a1552-4604
024 7 _a10.1177/0091270010366446
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWhitfield, Lloyd R
245 0 0 _aEffect of gemfibrozil and fenofibrate on the pharmacokinetics of atorvastatin.
_h[electronic resource]
260 _bJournal of clinical pharmacology
_cMar 2011
300 _a378-88 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAtorvastatin
650 0 4 _aBiotransformation
_xdrug effects
650 0 4 _aCross-Over Studies
650 0 4 _aDrug Interactions
650 0 4 _aEnzyme Inhibitors
_xblood
650 0 4 _aFemale
650 0 4 _aFenofibrate
_xblood
650 0 4 _aGemfibrozil
_xblood
650 0 4 _aHalf-Life
650 0 4 _aHeptanoic Acids
_xblood
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xblood
650 0 4 _aHyperlipidemias
_xdrug therapy
650 0 4 _aHypolipidemic Agents
_xblood
650 0 4 _aLactones
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPyrroles
_xblood
700 1 _aPorcari, Anthony R
700 1 _aAlvey, Christine
700 1 _aAbel, Robert
700 1 _aBullen, William
700 1 _aHartman, Daniel
773 0 _tJournal of clinical pharmacology
_gvol. 51
_gno. 3
_gp. 378-88
856 4 0 _uhttps://doi.org/10.1177/0091270010366446
_zAvailable from publisher's website
999 _c19770967
_d19770967